Effect of zinc oxide nanoparticles on neuroblastoma SH-SY5Y cells

American Journal of Biochemistry and Biotechnology

Volumn 10, Issue 2, 2014, Pages 116-124

  Zheng, Jinghui ^a   Schnurr, Theresia ^a   Dunlap, Kriya ^a   Das, Deben ^b   Duffy, Lawrence ^a  

^a UNIVERSITY OF ALASKA FAIRBANKS   (United States)

^b University of Alaska Fairbanks   (United States)

Author keywords

Nonmaterials; VEGF; ZnO Sh SY5Y cells

Indexed keywords

CELL CULTURE; CELLS; NANOPARTICLES; NANOSTRUCTURED MATERIALS; NANOTECHNOLOGY; NEURONS; SIGNAL TRANSDUCTION; TRANSMISSION ELECTRON MICROSCOPY;

CHEMICAL AND PHYSICAL PROPERTIES; NANOTECHNOLOGY INDUSTRY; NEUROBLASTOMA CELL LINES; NONMATERIALS; SH-SY5Y CELLS; SIGNAL TRANSDUCTION PATHWAYS; VEGF; ZINC OXIDE NANOPARTICLES;

ZINC OXIDE;

TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; ZINC OXIDE NANOPARTICLE;

ARTICLE; CELL CULTURE; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PARTICLE SIZE; PROTEIN DETERMINATION; SIGNAL TRANSDUCTION; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84903939249     PISSN: 15533468     EISSN: None     Source Type: Journal    
DOI: 10.3844/ajbbsp.2014.116.124     Document Type: Article

References (29)

1. Bai, W., Z. Zhang, W. Tian, X. He and Z. Chai et al., 2010. Toxicity of zinc oxide nanoparticles to zebrafish embryo: A physicochemical study of toxicity mechanism. J. Nanoparticle Res., 12: 1645-1654. DOI: 10.1007/s11051-009-9740-9
2. Breier, G., U. Albrecht, S. Sterrer and W. Risau, 1992. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development, 114: 521-532. PMID: 1592003
3. Borm, P.J., D. Robbins, S. Haubold, T. Kuhlbusch and H. Fissan et al., 2006. The potential risks of nanomaterials: A review carried out for ECETOC. Particle Fibre Toxicol., 3: 11. DOI: 10.1186/1743-8977-3-1
4. Boyle, J.J., 2005. Macrophage activation in atherosclerosis: Pathogenesis and pharmacology of plaque rupture. Curr. Vasc. Pharmacol., 3: 63-68. DOI: 10.2174/1570161052773861
5. Brown, L.F., B. Berse, K. Tognazzi, E.J. Manseau and S. Rosen et al., 1992a. Vascular permeability factor MRNA and protein expression in human kidney. Kidney Int., 42: 1457-1461. DOI: 10.1038/ki.1992.441
6. Brown, L.F., K.T. Yeo, B. Berse, T.K. Yeo and L. van de Water et al., 1992b. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J. Exp. Med., 176: 1375-1379. DOI: 10.1084/jem.176.5.1375
7. Bruneau, A., M. Fortier F. Gagne C. Gagnon P. Turcotte et al., 2013. Size distribution effects of cadmium tellurium quantum dots (CDS/CDTE) immunotoxicity on aquatic organisms. Environ. Sci. Processes Impacts, 15: 596-607. PMID: 23738358
8. Buzea, C., I.I. Pacheco and K. Robbie, 2007. Nanomaterials and nanoparticles: Sources and toxicity. Biointerphases, DOI: 10.1116/1.2815690
9. Cao, Y., H. Chen, L. Zhou, M.K. Chiang and B. Anand-Apte et al., 1996. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression and high affinity binding to Flk-1/KDR. J. Biol. Chem., 271: 3154-3162. PMID: 8621715
10. De Jong, W.H. and P.J. Borm, 2008. Drug delivery and nanoparticles: Applications and hazards. Int. J. Nanomedicine, 3: 133-149. DOI: 10.2147/IJN.S596
11. Dobrovolskaia, M.A., P. Aggarwal, J.B. Hall and S.E. McNeil, 2008. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Molecular Pharmaceut., 5: 487-495. DOI: 10.1021/mp800032f
12. Duffy, L.K., L. Nicholas-Figueroa, K. L. Dunlap, 2011. Involvement of cytokine il-1ra in regulating the secretion of VEGF in SH-SY5Y neuroblastoma. Int. J. Bioinformat. Biotechnol., 1: 2251-3159. DOI: 10.5176/ 2251-3159_1.1.1
13. Fava, R.A., N.J. Olsen, G. Spencer-Green, K.T. Yeo and L.F. Brown et al., 1994. Vascular permeability factor/endothelial growth factor (vpf/vegf): Accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J. Exp. Med., 180: 341-346. DOI: 10.1084/jem.180.1.341
14. Ferrara, N., J. Winer and T. Burton, 1991. Aortic smooth muscle cells express and secrete vascular endothelial growth factor. Growth Factors, 5: 141-148. DOI: 10.3109/08977199109000278
15. Gustafson, S.J., K.L. Dunlap, C.M. McGill and T.B. Kuhn, 2012. A nonpolar blueberry fraction blunts NADPH oxidase activation in neuronal cells exposed to tumor necrosis factor-alpha. Oxidative Med. Cellular Longevity, 2012: 768101. DOI: 10.1155/2012/768101.
16. Hopkins, S.J., C.J. McMahon, N. Singh, J. Galea and P.J. Tyrrel et al., 2012. Cerebrospinal fluid and plasma cytokines after subarachnoid haemorrhage: CSF interleukin-6 may be an early marker of infection. J. Neuroinflammation. DOI: 10.1186/1742-2094-9-255.
17. Iijima, K., N. Yoshikawa, D.T. Connolly and H. Nakamura, 1993. Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factor. Kidney Int., 44: 959-966. DOI: 10.1038/ki.1993.337
18. Kemp, S.W., A.J. Reynolds and L.K. Duffy, 2005. Gender differences in baseline levels of vascular endothelial growth factor in the plasma of alaskan sled dogs. Am. J. Biochem. Biotechnol., 1: 111-114. DOI: 10.3844/ajbbsp.2005.111.114
19. Kerbel, S.R., 2000. Tumor angiogenesis: Past, present and the near future. Carcinogenesis, 21: 505-515. DOI: 10.1093/carcin/21.3.505
20. Koch, A.E., L.A. Harlow, G.K. Haines, E.P. Amento and E.N. Unemori, 1994. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J. Immunol., 152: 4149-56. PMID: 7511670
21. Kondo, S., M. Asano, K. Matsuo, I. Ohmori and H. Suzuki, 1994. Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. Biochim. Biophys. Acta, 1221: 211-214. PMID: 8148401
22. Kumari, M., S.S. Khan, S. Pakrashi, A. Mukherjee and N. Chandrasekaran, 2011. Cytogenetic and genotoxic effects of zinc oxide nanoparticles on root cells of allium cepa. J. Hazardous Mater., 190: 613-21. DOI: 10.1016/j.jhazmat.2011.03.095
23. Monacci, W.T., M.J. Merrill and E.H. Oldfield, 1993. Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am. J. Physiol., 264: 995-1002. PMID: 8476026
24. Nowack, B. and D.T. Bucheli, 2007. Review: Occurrence, behavior and effects of nanoparticles in the environment. Environ. Poll., 150: 5-22. DOI: 10.1016/j.envpol.2007.06.006a
25. Pertovaara, L., A. Kaipainen, T. Mustonen, A. Orpana and N. Ferrara et al., 1994. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J. Biol. Chem., 269: 6271-6274. PMID: 8119973
26. Roskoski, J.R., 2007. Vascular Endothelial Growth Factor (VEGF) signaling in tumor progression. Oncol. Hematol., 62: 179-213. PMID: 17324579
27. Senger, D.R., L. Van de Water, L.F. Brown, J.A. Nagy and K.T. Yeo et al., 1993. Vascular Permeability Factor (VPF, VEGF) in tumor biology. Can. Metast. Rev., 12: 303-24. DOI: 10.1007/BF00665960
28. Storkebaum, E. and P. Carmeliet, 2004. Vegf: A critical player in neurodegeneration. J. Clin. Invest., 113: 14-8. DOI: 10.1172/JCI20682
29. Yang, Z., Z.W. Liu, R.P. Allaker, P. Reip and J. Oxford et al., 2010. A review of nanoparticle functionality and toxicity on the central nervous system. J. Royal Society, 7: S411-22. DOI: 10.1098/ rsif.2010.0158.focus